JPMorgan analyst James Gordon raised the firm’s price target on Grifols (GRFS) to $10.30 from $7.60 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRFS:
- Grifols Completes Acquisition of Biotest Shares Following Delisting
- Grifols Announces Leadership Changes and Financial Results at June 2025 Shareholders’ Meeting
- U.S. court rules to go on with Grifol lawsuit against Gotham City, Reuters says
- Grifols SA Reports Strong Q1 2025 Financial Performance
- Grifols SA Reports Strong Q1 2025 Earnings